Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: A potential target for future therapeutics?

Current Drug Targets

Volumn 16, Issue 10, 2015, Pages 1088-1093

  Sullivan, Mitchell A ^a,e   Harcourt, Brooke E ^b,c   Xu, Ping ^d   Forbes, Josephine M ^b   Gilbert, Robert G ^a,e  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Db Db; diabetes; drug targets; glycogen; glycogenolysis; liver; molecular structure

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DIMETHYL SULFOXIDE; GLYCOGEN PHOSPHORYLASE; LEPTIN; GLYCOGEN LIVER LEVEL;

DB/DB MOUSE; DISEASE MODEL; GENE MUTATION; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOGEN STORAGE DISEASE; HUMAN; LIGHT DARK CYCLE; LIVER GLYCOGEN STORAGE DISEASE; LIVER SIZE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PROTEIN STRUCTURE; REVIEW; SATIETY; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; ULTRASTRUCTURE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; LEPTIN; LIVER GLYCOGEN; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84945953295     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450116666150727123115     Document Type: Review

References (52)

1. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310(9): 948-59.
2. Aronoff SL, Berkowitz K, Shreiner B, Want L. Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spect 2004; 17(3): 183-90.
3. Hazard B, Zhang XQ, Colasuonno P, Uauy C, Beckles DM, Dubcovsky J. Induced mutations in the starch branching enzyme ii (sbeii) genes increase amylose and resistant starch content in durum wheat. Crop Sci 2012; 52(4): 1754-66.
4. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999; 19: 379-406.
5. Meyer F, Heilmeyer L, Haschke RH, Fischer EH. Control of phosphorylase activity in a muscle glycogen particle.1. Isolation and characterization of protein-glycogen complex. J Biol Chem 1970; 245(24): 6642-8.
6. Rybicka KK. Glycosomes - The organelles of glycogen metabolism. Tissue Cell 1996; 28(3): 253-65.
7. Reikeras O, Nordstrand K, Henden T. Effects of fasting and glucose insulin potassium on glycogen contents in heart, skeletalmuscle and liver. Scand J Clin Lab Invest 1988; 48(3): 285-8.
8. Besford QA, Sullivan MA, Zheng L, Gilbert RG, Stapleton D, Gray-Weale A. The structure of cardiac glycogen in healthy mice. Int J Biol Macromol 2012; 51(5): 887-91.
9. Darnton SJ. Glycogen metabolism in rabbit kidney under differing physiological states. Q J Exp Physiol Cogn Med Sci 1967; 52(4): 392-400.
10. Hummel KP, Dickie MM, Coleman DL. Diabetes a new mutation mouse. Science 1966; 153(3740): 1127-8.
11. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950; 41(12): 317-8.
12. Dickie MM, Lane PW. Plus letter to Roy Robinson 7/7/70. Mouse News Lett 1957; 17: 52.
13. Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homolog. Nature 1994; 372(6505): 425-32.
14. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83(7): 1263-71.
15. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84(3): 491-5.
16. Coleman DL. A historical perspective on leptin. Nat Med 2010; 16(10): 1097-9.
17. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 1969; 217(5): 1298-304.
18. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9(4): 294-8.
19. Alftren J, Penarrieta JM, Bergenstahl B, Nilsson L. Comparison of molecular and emulsifying properties of gum arabic and mesquite gum using asymmetrical flow field-flow fractionation. Food Hydrocolloids 2012; 26(1): 54-62.
20. Sullivan MA, Vilaplana F, Cave RA, Stapleton DI, Gray-Weale AA, Gilbert RG. Nature of alpha and beta particles in glycogen using molecular size distributions. Biomacromolecules 2010; 11(4): 1094-100.
21. Sullivan MA, O'Connor MJ, Umana F, et al. Molecular insights into glycogen alpha-particle formation. Biomacromolecules 2012; 13(11): 3805-13.
22. Powell PO, Sullivan MA, Sheehy JJ, Schultz BL, Warren FJ, Gilbert RG. Acid hydrolysis and molecular density of phytoglycogen and liver glycogen helps with understanding the bonding in alpha (composite) glycogen molecules. PLoS One 2015; 10(3): e0121337.
23. Deng B, Sullivan MA, Li J, et al. Molecular structure of glycogen in diabetic liver. Glucoconjugate J 2015; 32(3-4): 113-8.
24. Sullivan MA, Powell PO, Witt T, Vilaplana F, Roura E, Gilbert RG. Improving size-exclusion chromatography for glycogen. J Chromatogr A. 2014; 1332(1): 21-9.
25. Stapleton D, Nelson C, Parsawar K, McClain D, Gilbert-Wilson R, Barker E, et al. Analysis of hepatic glycogen-associated proteins. Proteomics 2010; 10(12): 2320-9.
26. Roesler WJ, Khandelwal RL. Kinetic properties of glycogen synthase and phosphorylase and structural aspects of glycogen in the db/db mouse liver. Diabetes 1986; 35(2): 210-6.
27. Roesler WJ, Pugazhenthi S, Khandelwal RL. Hepatic glycogen metabolism in the db/db mouse. Mol Cell Biochem 1990; 92: 99- 106.
28. Sullivan MA, Li J, Li C, et al. Molecular structural differences between type-2-diabetic and healthy glycogen. Biomacromolecules 2011; 12(6): 1983-6.
29. Gilbert RG, Sullivan MA. The molecular size distribution of glycogen and its relevance to diabetes (review). Aust J Chem 2014; 67(4): 538-43.
30. Stetten MR, Stetten Jr. D. Influence of molecular size of glycogen on the phosphorylase reaction. J Biol Chem 1958; 232(1): 489-504.
31. Barber AA, Orrell SA, Bueding E. Association of enzymes with rat liver glycogen isolated by rate-zonal centrifugation. J Biol Chem 1967; 242(18): 4040-44.
32. Orrell SA, Bueding E. A comparison of products obtained by various procedures used for the extraction of glycogen. J Biol Chem 1964; 239(12): 4021-6.
33. Sullivan MA, Aroney STN, Li S, et al. Changes in glycogen structure over feeding cycle sheds new light on blood-glucose control. Biomacromolecules 2014; 15(2): 660-5.
34. Melendez R, Melendez-Hevia E, Mas F, Mach J, Cascante M. Physical constraints in the synthesis of glycogen that influence its structural homogeneity: a two-dimensional approach. Biophys J 1998; 75(1): 106-14.
35. Stearns SB, Benzo CA. Structural and chemical alterations associated with hepatic glycogen-metabolism in genetically diabetic (db) and in streptozotocin-induced diabetic mice. Lab Invest 1977; 37(2): 180-7.
36. Coleman DL, Hummel KP. Studies with the mutation, diabetes, in the mouse. Diabetologia 1967; 3(2): 238-48.
37. Chan TM, Young KM, Hutson NJ, Brumley FT, Exton JH. Hepatic- metabolism of genetically diabetic (db-db) mice.1. Carbohydrate- metabolism. Am J Physiol 1975; 229(6): 1702-12.
38. Roesler WJ, Helgason C, Gulka M, Knandelwal RL. Aberrations in the diurnal rhythms of plasma-glucose, plasma-insulin, liverglycogen, and hepatic glycogen-synthase and phosphorylase activities in genetically diabetic (db/db) mice. Horm Metab Res 1985; 17(11): 572-5.
39. Higgins GM, Berkson J, Flock E. The diurnal cycle in the liver I. Periodicity of the cycle, with analysis of chemical constituents involved. Am J Physiol 1932; 102(3): 673-82.
40. Soilberger A. The control of circadian glycogen rhythms. Ann N Y Acad Sci 1964; 117: 519-54.
41. Cohn C, Joseph D. Feeding habits and daily rhythms in tissue glycogens in rat. Proc Soc Exp Biol Med 1971; 137(4): 1303-6.
42. Ono M, Ichihara J, Nonomura T, et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 1997; 238(2): 633-7.
43. Tonra JR, Ono M, Liu X, et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in (C57BLKS-Lepr db/lepr db) mice. Diabetes 1999; 48(3): 588-94.
44. Macauley M, Smith FE, Thelwall PE, Hollingsworth KG, Taylor R. Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes. Clin Sci (Lond) 2015; 128(10): 707-13.
45. Stephenson MC, Leverton E, Khoo EYH, et al. Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a H-1 and C-13 MRS study. NMR Biomed 2013; 26(11): 1518-26.
46. He J, Kelley DE. Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2004; 287(5): E1002-E7.
47. Krssak M, Brehm A, Bernroider E, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004; 53(12): 3048-56.
48. Qian YM, Bolin DR, Conde-Knape K, et al. N-substituted sultam carboxylic acids as novel glycogen synthase activators. Medchemcomm 2013; 4(5): 833-8.
49. Motawi TMK, Bustanji Y, El-Maraghy SA, Taha MO, Al Ghussein MAS. Naproxen and cromolyn as new glycogen synthase kinase 3 inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation. J Biochem Mol Toxicol 2013; 27(9): 425-36.
50. Eldar-Finkelman H, Ilouz R. Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment. Expert Opin Investig Drugs 2003; 12(9): 1511-9.
51. Loughlin WA. Recent advances in the allosteric inhibition of glycogen phosphorylase. Mini Rev Med Chem 2010; 10(12): 1139-55.
52. Sullivan MA, Li S, Aroney ST, et al. A rapid extraction method for glycogen from formalin-fixed liver. Carbohydr Polym 2015; 118(1): 9-15.